Pascal E.R. Girin's most recent trade in ClearPoint Neuro Inc was a trade of 523 Common Stock done at an average price of $11.9 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 11.94 per share. | 01 Jul 2025 | 523 | 96,634 (0%) | 0% | 11.9 | 6,245 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,417 | 12,417 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 96,111 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 11.89 per share. | 01 Apr 2025 | 525 | 75,018 (0%) | 0% | 11.9 | 6,242 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 02 Jan 2025 | 406 | 74,493 (0%) | 0% | 15.4 | 6,244 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 11.21 per share. | 01 Oct 2024 | 557 | 74,087 (0%) | 0% | 11.2 | 6,244 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 01 Jul 2024 | 1,333 | 73,530 (0%) | 0% | 5.4 | 7,185 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 21,093 | 21,093 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 72,197 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 6.80 per share. | 01 Apr 2024 | 1,056 | 55,044 (0%) | 0% | 6.8 | 7,181 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 6.79 per share. | 02 Jan 2024 | 1,058 | 53,988 (0%) | 0% | 6.8 | 7,184 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 7.24 per share. | 03 Jul 2023 | 992 | 51,496 (0%) | 0% | 7.2 | 7,182 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 17,153 | 17,153 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 8.44 per share. | 03 Apr 2023 | 851 | 50,504 (0%) | 0% | 8.4 | 7,182 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 7.97 per share. | 03 Jan 2023 | 901 | 49,653 (0%) | 0% | 8.0 | 7,181 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 10.19 per share. | 03 Oct 2022 | 705 | 48,752 (0%) | 0% | 10.2 | 7,184 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 12.63 per share. | 01 Jul 2022 | 668 | 48,047 (0%) | 0% | 12.6 | 8,437 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,269 | 47,379 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,179 | 6,179 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 9.96 per share. | 01 Apr 2022 | 847 | 38,110 (0%) | 0% | 10.0 | 8,436 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 11.54 per share. | 01 Jan 2022 | 730 | 37,263 (0%) | 0% | 11.5 | 8,424 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 17.92 per share. | 01 Oct 2021 | 470 | 36,533 (0%) | 0% | 17.9 | 8,422 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 20.26 per share. | 30 Jun 2021 | 296 | 36,063 (0%) | 0% | 20.3 | 5,997 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 6,006 | 6,006 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 3,003 | 35,767 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 19.57 per share. | 31 Mar 2021 | 322 | 32,764 (0%) | 0% | 19.6 | 6,302 | Common Stock |
| ClearPoint Neuro Inc | Pascal E.R. Girin | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 996 | 32,063 (0%) | 0% | 5.7 | 5,687 | Common Stock |